Earlier in July 2026, a federal judge blocked Colorado’s plan to impose a very large price cut on Amgen’s arthritis drug Enbrel, halting one of the most aggressive state-level attempts to cap branded ...
Source LinkEarlier in July 2026, a federal judge blocked Colorado’s plan to impose a very large price cut on Amgen’s arthritis drug Enbrel, halting one of the most aggressive state-level attempts to cap branded ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.